Public urged to stop taking Rosabella's Moringa capsules over possible salmonella contamination: HSA


PUBLISHED ONMarch 01, 2026 10:45 PMBYSean LerSingapore's Communicable Diseases Agency (CDA) and Health Sciences Authority (HSA) have flagged a supplement which may have been contaminated by salmonella, which is resistant to multiple key antibiotics.
In an advisory issued on Sunday (March 1), the agencies urged the public to immediately stop taking affected lots of the Rosabella brand Moringa power capsules made by Ambrosia Brands LLC.
Consumers are also advised to dispose of the product safely by placing them in a sealed bag with general household waste, and not open the capsules or flush them down toilets and drains.
The agencies said they were aware of a recall in the US of specific lots of the said product due to possible contamination by salmonella.
They added that there have been seven salmonellosis cases in the US linked to the affected product, resulting in three hospitalisations and no deaths.
The affected lots are:
| Product name | Lot number | Expiry date |
| Rosabella Moringa capsules | 5020-591 to 596 | 03/2027 |
| 5030-246 to 251 | 04/2027 | |
| 5040-270 to 279 | 05/2027 | |
| 5050-053 to 086 | 06/2027 | |
| 5060-069 to 086 | 07/2027 | |
| 5080-084 to 086 | 09/2027 | |
| 5090-107 to 118 | 10/2027 | |
| 51000039 | 11/2027 | |
| 51000048 | 11/2027 |
Salmonella is "extensively drug resistant" to multiple key antibiotics. This can lead to patients having limited treatment options and increased risk of severe complications.
Symptoms include diarrhoea, fever, nausea, stomach cramps and vomiting. Such symptoms usually develop six to 72 hours after consumption and can last between four and seven days. The elderly, those pregnant, and people with weakened immune systems may experience more severe illnesses that require medical treatment or hospitalisation.
CDA and HSA said there are currently no reported cases in Singapore of extensively drug-resistant salmonella associated with the consumption of the said product.
As salmonellosis is a notifiable disease under the Infectious Diseases Act, the authorities have alerted hospitals and are conducting surveillance with them to monitor for such cases. HSA is also monitoring if there are any local adverse events relating to this issue.
[[nid:725531]]